{
    "2021-06-25": [
        [
            {
                "time": "",
                "original_text": "首款CAR-T获批小玩家却笑不出来 监管严可能只有3张“门票”怎么办？",
                "features": {
                    "keywords": [
                        "CAR-T",
                        "获批",
                        "监管",
                        "门票"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年度半年度投资策略：医改新常态 下 紧扣创新+消费投资主线",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "医改",
                        "创新",
                        "消费"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中信证券：预计带量采购对未来市场冲击边际减小，创新研发将成为药企发展核心",
                "features": {
                    "keywords": [
                        "中信证券",
                        "带量采购",
                        "市场冲击",
                        "创新研发",
                        "药企发展"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "产品定价几许 引发关注",
                "features": {
                    "keywords": [
                        "产品定价",
                        "关注"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "南向资金高比例持有港股名单",
                "features": {
                    "keywords": [
                        "南向资金",
                        "港股",
                        "持有"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "港股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}